Psychological Treatments for Depression and Anxiety in Dementia and Mild Cognitive Impairment: Systematic Review and Meta-analysis

Overview

Journal Br J Psychiatry

Publisher Cambridge University Press

Specialty Psychiatry

Date 2015 Oct 3

PMID 26429684

Citations 66

Authors

Vasiliki Orgeta

Afifa Qazi

Aimee Spector

Martin Orrell

Affiliations

Soon will be listed here.

Abstract

Background: Anxiety and depression are common in people with dementia and mild cognitive impairment (MCI), but there is uncertainty about the effectiveness of both pharmacological and psychological therapies.

Aims: To evaluate the evidence of effectiveness of psychological treatments in treating depression and anxiety in people with dementia and MCI.

Method: We carried out a systematic review and meta-analysis of randomised controlled trials (RCTs) of psychological treatment versus usual care in people with dementia and MCI. Primary outcomes were symptoms of anxiety and depression. Secondary outcomes were quality of life, ability to perform daily activities, neuropsychiatric symptoms, cognition and caregivers' self-rated depressive symptoms.

Results: We included six RCTs, involving 439 participants with dementia, which used cognitive-behavioural therapy, interpersonal therapy, counselling or multimodal interventions including a specific psychological therapy. We found beneficial effects for both depression and anxiety. Overall, the quality of the evidence was moderate for depression and low for anxiety, due to the methodological limitations of the studies we identified and the limited number of trials.

Conclusions: The evidence from six RCTs suggests that psychological treatments are effective in reducing symptoms of depression and anxiety for people with dementia. There is a need for high-quality, multicentre trials including standardised, well-defined interventions.

Citing Articles

Sleep deprivation in dementia comorbidities: focus on cardiovascular disease, diabetes, anxiety/depression and thyroid disorders.

Mukherjee U, Sehar U, Brownell M, Reddy P Aging (Albany NY). 2024; 16(21):13409-13429.

PMID: 39571101 PMC: 11719105. DOI: 10.18632/aging.206157.

Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trial.

Panca M, Howard R, Cort E, Rawlinson C, Gould R, Wiegand M BJPsych Open. 2024; 10(6):e189.

PMID: 39450544 PMC: 11698147. DOI: 10.1192/bjo.2024.775.

No one left to cope alone (NOLA): protocol for the development of a postdiagnostic intervention to support people newly diagnosed with dementia.

Stoner C, Durgante H, Birt L, Spector A BMJ Open. 2024; 14(10):e091241.

PMID: 39395829 PMC: 11474887. DOI: 10.1136/bmjopen-2024-091241.

Network analysis of anxiety and cognitive impairment among mental healthcare workers.

Chen R, Yan W, Shen Q, Li M, Chen M, Dong J Front Psychiatry. 2024; 15:1393598.

PMID: 39234623 PMC: 11371607. DOI: 10.3389/fpsyt.2024.1393598.

Benefits Perceived by Caregivers of Patients with Alzheimer's Disease on Physical and Emotional Health in an Interdisciplinary Program: A Qualitative Study.

Urbano-Mairena J, de Los Rios-Calonge J, Postigo-Mota S, Carvajal-Gil J, Silveira-Saraiva E, Guerra-Bustamante J Healthcare (Basel). 2024; 12(14).

PMID: 39057557 PMC: 11275445. DOI: 10.3390/healthcare12141414.

References

Monastero R, Mangialasche F, Camarda C, Ercolani S, Camarda R . A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis. 2009; 18(1):11-30. DOI: 10.3233/JAD-2009-1120. View

Lu P, Edland S, Teng E, Tingus K, Petersen R, Cummings J . Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology. 2009; 72(24):2115-21. PMC: 2697965. DOI: 10.1212/WNL.0b013e3181aa52d3. View

Solfrizzi V, DIntrono A, Colacicco A, Capurso C, Del Parigi A, Caselli R . Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the Italian longitudinal study on aging. Dement Geriatr Cogn Disord. 2007; 24(1):55-64. DOI: 10.1159/000103632. View

Petersen R, Smith G, Waring S, Ivnik R, Tangalos E, Kokmen E . Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999; 56(3):303-8. DOI: 10.1001/archneur.56.3.303. View

Burgener S, Yang Y, Gilbert R, Marsh-Yant S . The effects of a multimodal intervention on outcomes of persons with early-stage dementia. Am J Alzheimers Dis Other Demen. 2008; 23(4):382-94. PMC: 3014218. DOI: 10.1177/1533317508317527. View

Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R . Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011; 378(9789):403-11. DOI: 10.1016/S0140-6736(11)60830-1. View

Spector A, Orrell M, Davies S, Woods R . Reminiscence therapy for dementia. Cochrane Database Syst Rev. 2000; (4):CD001120. DOI: 10.1002/14651858.CD001120. View

Petracca G, Chemerinski E, Starkstein S . A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease. Int Psychogeriatr. 2001; 13(2):233-40. DOI: 10.1017/s104161020100761x. View

Lyketsos C, Steele C, Baker L, Galik E, Kopunek S, Steinberg M . Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin Neurosci. 1998; 9(4):556-61. DOI: 10.1176/jnp.9.4.556. View

10.

Enache D, Winblad B, Aarsland D . Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry. 2011; 24(6):461-72. DOI: 10.1097/YCO.0b013e32834bb9d4. View

11.

Gitlin L, Winter L, Corcoran M, Dennis M, Schinfeld S, Hauck W . Effects of the home environmental skill-building program on the caregiver-care recipient dyad: 6-month outcomes from the Philadelphia REACH Initiative. Gerontologist. 2003; 43(4):532-46. DOI: 10.1093/geront/43.4.532. View

12.

Schultz S, Hoth A, Buckwalter K . Anxiety and impaired social function in the elderly. Ann Clin Psychiatry. 2004; 16(1):47-51. DOI: 10.1080/10401230490281429. View

13.

Lopez O, Becker J, Sweet R . Non-cognitive symptoms in mild cognitive impairment subjects. Neurocase. 2005; 11(1):65-71. DOI: 10.1080/13554790490896893. View

14.

Rozzini L, Chilovi B, Peli M, Conti M, Rozzini R, Trabucchi M . Anxiety symptoms in mild cognitive impairment. Int J Geriatr Psychiatry. 2008; 24(3):300-5. DOI: 10.1002/gps.2106. View

15.

Bains J, Birks J, Dening T . Antidepressants for treating depression in dementia. Cochrane Database Syst Rev. 2003; (4):CD003944. DOI: 10.1002/14651858.CD003944. View

16.

Brodaty H, Arasaratnam C . Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatry. 2012; 169(9):946-53. DOI: 10.1176/appi.ajp.2012.11101529. View

17.

Spector A, Orrell M, Lattimer M, Hoe J, King M, Harwood K . Cognitive behavioural therapy (CBT) for anxiety in people with dementia: study protocol for a randomised controlled trial. Trials. 2012; 13:197. PMC: 3495021. DOI: 10.1186/1745-6215-13-197. View

18.

Lyketsos C, DelCampo L, Steinberg M, Miles Q, Steele C, Munro C . Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psychiatry. 2003; 60(7):737-46. DOI: 10.1001/archpsyc.60.7.737. View

19.

Tappen R, Williams C . Therapeutic conversation to improve mood in nursing home residents with Alzheimer's disease. Res Gerontol Nurs. 2010; 2(4):267-75. DOI: 10.3928/19404921-20090428-02. View

20.

Waldorff F, Buss D, Eckermann A, Rasmussen M, Keiding N, Rishoj S . Efficacy of psychosocial intervention in patients with mild Alzheimer's disease: the multicentre, rater blinded, randomised Danish Alzheimer Intervention Study (DAISY). BMJ. 2012; 345:e4693. PMC: 3398860. DOI: 10.1136/bmj.e4693. View